Tianmei M. Zeng
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Superior survival benefits of triple combination immunotherapy compared to standard chemotherapy as second-line treatment for advanced biliary tract cancer: a retrospective analysis.
Journal: Frontiers in oncology
Published: August 19, 2024
Genomic and Immune Features in an Intrahepatic Cholangiocarcinoma Patient with Microsatellite Instability-High Suffered Rapid Acquired Resistance to PD-1 Inhibitor.
Journal: Liver cancer
Published: July 28, 2022
Immune-related lncRNA signature delineates an immune-excluded subtype of liver cancer with unfavorable clinical outcomes.
Journal: Journal of clinical laboratory analysis
Published: November 25, 2021
PD-1 Inhibitors Plus Capecitabine as Maintenance Therapy for Advanced Intrahepatic Cholangiocarcinoma: A Case Report and Review of Literature.
Journal: Frontiers in immunology
Published: October 22, 2021
Prognosis of Advanced Cholangiocarcinoma in the Palliative Care Setting: A Series of 201 Cases.
Journal: Alternative therapies in health and medicine
Published: October 15, 2021
Camrelizumab in advanced or metastatic solid tumour patients with DNA mismatch repair deficient or microsatellite instability high: an open-label prospective pivotal trial.
Journal: Journal of cancer research and clinical oncology
Published: January 08, 2020
The significance of serum IgD quantitation for evaluation of clinical efficacy in IgD multiple myeloma
Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Published: April 21, 2016
LC-MS/MS method for simultaneous determination of thalidomide, lenalidomide, cyclophosphamide, bortezomib, dexamethasone and adriamycin in serum of multiple myeloma patients.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences
Published: March 03, 2016
Efficacy and prognostic factors of induction therapy combined with autologous stem cell transplantation in 201 patients with multiple myeloma
Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Published: February 16, 2016
Safety and prognosis of allogenetic stem cell transplantation in younger patients with multiple myeloma
Journal: Zhonghua yi xue za zhi
Published: January 22, 2016
Response and prognosis of patients with multiple myeloma induced by PAD/TAD
Journal: Zhonghua yi xue za zhi
Published: June 18, 2015
Multiple myeloma patients at various cytogenetic risks benefit differently from autologous stem cell transplantation as a consolidation therapy.
Journal: Stem cells international
Published: October 28, 2014
Last Updated: 09/26/2026